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Capsules are surface layers of hydrated capsular polysaccharides
(CPSs) produced by many bacteria. The human pathogen Salmo-
nella enterica serovar Typhi produces “Vi antigen” CPS, which con-
tributes to virulence. In a conserved strategy used by bacteria with
diverse CPS structures, translocation of Vi antigen to the cell sur-
face is driven by an ATP-binding cassette (ABC) transporter. These
transporters are engaged in heterooligomeric complexes proposed
to form an enclosed translocation conduit to the cell surface,
allowing the transporter to power the entire process. We identi-
fied Vi antigen biosynthesis genetic loci in genera of the Burkhol-
deriales, which are paradoxically distinguished from S. Typhi by
encoding VexL, a predicted pectate lyase homolog. Biochemical
analyses demonstrated that VexL is an unusual metal-independent
endolyase with an acidic pH optimum that is specific for O-
acetylated Vi antigen. A 1.22-Å crystal structure of the VexL-Vi
antigen complex revealed features which distinguish common se-
creted catabolic pectate lyases from periplasmic VexL, which par-
ticipates in cell-surface assembly. VexL possesses a right-handed
parallel β-superhelix, of which one face forms an electropositive
glycan-binding groove with an extensive hydrogen bonding net-
work that includes Vi antigen acetyl groups and confers substrate
specificity. VexL provided a probe to interrogate conserved features
of the ABC transporter-dependent export model. When introduced
into S. Typhi, VexL localized to the periplasm and degraded Vi an-
tigen. In contrast, a cytosolic derivative had no effect unless export
was disrupted. These data provide evidence that CPS assembled in
ABC transporter-dependent systems is actually exposed to the peri-
plasm during envelope translocation.
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Most bacterial cell surfaces are dominated by carbohydrate-containing molecules, which modulate interactions with
the external environment. Some bacteria, including several sig-
nificant human pathogens, produce a capsule, which is a cell-
surface layer composed of hydrated polysaccharide. The mech-
anism for tethering the polysaccharide to the cell surface is not
known in all cases, but prevalent systems in Gram-negative
bacteria use terminal glycolipids (1, 2). Capsular polysaccha-
rides (CPSs) allow some commensals to influence homeostasis of
the host immune system, mediate host interactions by plant
symbionts, are receptors for bacteriophages, and are established
virulence factors in pathogens. In pathogens, capsules interrupt
innate immune responses by masking cell-surface pathogen-
associated molecular patterns (PAMPs), reducing serum com-
plement deposition and limiting phagocytosis (3, 4).
Selective pressures have led to enormous diversity in CPS
structures, reflected as variation in monosaccharide composition,
linkage, and nonsugar decoration. More than 80 CPS structures
have been identified in Escherichia coli isolates alone (5). De-
spite structural diversity in CPS glycans, the protein machinery
for their assembly and secretion is conserved. The two CPS as-
sembly strategies in Gram-negative bacteria employ different
modes of translocation across the inner membrane (5). This
step is facilitated by either a multidrug/oligosaccharidyl-lipid/
polysaccharide export (MOP) “flippase” (Wzx) (reviewed in ref.
6), or an ATP-binding cassette (ABC) transporter (reviewed in
refs. 2 and 7). This work focuses on the latter strategy, which is
often referred to by its classification in E. coli as “group 2”
capsule assembly (5). This strategy is shared by a range of en-
capsulated pathogens including meningococci, Haemophilus
influenzae, Campylobacter jejuni, Bordetella pertussis, and Sal-
monella enterica serovar Typhi (2). Prototypes for group 2 ABC
transporter-dependent CPS assembly are provided by E. coli
serotype K1 and K5 CPSs. These CPS glycans are assembled at
the cytoplasm-membrane interface on a conserved glycolipid
consisting of ∼5 to 9 β-linked 3-deoxy-β-D-manno-oct-2-ulosonic
acid (Kdo) residues attached to a reducing terminal (lyso)
phosphatidylglycerol (lysoPG) (1). The resulting glycolipid is the
acceptor for different CPS structures in a wide range of bacterial
species (2, 7). Serotype-specific glycosyltransferases extend lysoPG-
oligo-Kdo in the cytoplasm (1, 7). The glycolipid terminus is
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likely recognized by the ABC transporter as an export signal
(reviewed in ref. 2).
Glyco-ABC transporters are composed of two copies each of a
transmembrane domain (TMD) and a nucleotide-binding do-
main (NBD), encoded by kpsM and kpsT in E. coli, respectively.
ATP binding and hydrolysis in the NBD dimer drives confor-
mational changes in the TMD dimer that power CPS secretion
across the inner membrane (reviewed in refs. 2 and 8). Trans-
location of CPS across the periplasm and outer membrane em-
ploys a heterooligomeric complex composed of polysaccharide
copolymerase (PCP) and outer membrane polysaccharide export
(OPX) proteins (reviewed in ref. 9). The current model proposes
that these components form a contiguous envelope-spanning
channel resembling some bacterial tripartite drug efflux pumps.
In efflux pumps, an inner membrane flippase (10), or ABC trans-
porter (11), interfaces with the outer membrane porin (TolC)
through interactions with a periplasmic adaptor protein complex.
Available structure and protein interaction data (reviewed in ref.
5) drive the hypothesis that the CPS ABC transporter resides
within a complex composed of the transporter, a PCP protein
adaptor, and an OPX channel (Fig. 1). However, there is currently
no atomic-level data for PCP or OPX proteins from ABC transporter-
dependent systems, and this hypothetical export pathway has not
been interrogated experimentally.
Vi antigen is a CPS produced by S. enterica serovar Typhi, the
etiological agent of typhoid fever, a disease that afflicts millions
each year. Vi antigen is composed of the repeating monosaccha-
ride unit [→4)-α-D-GalNAcA-(1→]n which is nonstoichiometri-
cally O-acetylated at C-3 (12). It is exploited in current vaccines
(13). Like K1 and K5 CPSs, Vi antigen assembly employs an ABC
transporter complex, which is encoded by vexB (TMD), vexC
(NBD), vexD (PCP), and vexA (OPX) (Fig. 1) (14, 15). However,
the Vi antigen glycolipid terminus and synthesis machinery is
distinct from E. coli prototypes in that Vi antigen possesses a
reducing-terminal N-acetylhexosamine residue decorated with two
β-hydroxyacyl chains, instead of oligo-Kdo-lysoPG (16).
Genes for Vi antigen production are found in some soil bac-
teria, including Achromobacter denitrificans and Bordetella petrii
(16). Paradoxically, these Vi antigen-assembly systems include
VexL, a predicted homolog of pectate lyases that depolymerizes
Vi antigen in vitro; VexL is absent from S. Typhi (16). To de-
termine whether VexL was simply a catabolic enzyme with broad
specificity, we investigated its structure and function. We found
that VexL is a periplasmic Vi antigen-specific lyase enzyme. The
structure of the VexL–Vi antigen complex was solved by X-ray
crystallography and defined amino acid residues important for
activity and specificity. Depolymerizing enzymes are unprece-
dented in CPS assembly systems and conflict with current con-
ceptual models for secretion that include a privileged periplasmic
channel. The discovery of VexL provided an opportunity to test
this model. We therefore examined the effect of introducing VexL
into S. Typhi, which revealed insights into the molecular mecha-
nism of the ABC transporter-dependent CPS secretion that is
conserved in many clinically important bacterial pathogens.
Results
VexL Is a Pectate Lyase Homolog Conserved in Burkholderiales Vi
Antigen Assembly Systems. We identified vexL in the Vi antigen
biosynthesis genetic locus (viaB) of Achromobacter denitrificans
(16). Homologs of VexL belonged to the ambrosia allergen
protein family, which contains pectate lyase enzymes (Conserved
Domain Database) (16, 17). The structure of Vi antigen super-
ficially resembles pectin (which has the repeat unit structure
[→4)-D-GalA-α-(1→]n), and we hypothesized that VexL was a
pectate lyase homolog with Vi antigen depolymerase activity
(16). Vi-antigen depolymerization had been demonstrated in
vitro (16), but substrate specificity remained untested. Further-
more, the presence of a signal sequence (mean D score residues
1 to 23 = 0.73, cutoff = 0.57, SignalP4.1) (18) suggested that
VexL is an exported protein but gave no insight into its final
cellular location or biological function.
To expand our understanding of this enzyme, position-specific
iterative BLAST (19) was used to identify additional homologs
of VexL; hits were plant pectate lyases or bacterial enzymes
within the Order Burkholderiales (Fig. 2). The Burkholderiales
homologs shared 65 to 89% identity with A. denitrificans VexL.
Interestingly, classical characterized bacterial pectate lyases A
and C from Dickeya dadanti (20, 21) and Bacillus subtilis (22)
were not identified, for example. When the phylogeny of these
enzymes was investigated, bacterial VexL homologs and known
bacterial pectate lyases clustered separately from representatives
from plants (Fig. 2). Furthermore, Burkholderiales VexL form a
distinct clade separate from characterized bacterial pectate ly-
ases. The genes encoding VexL-clade enzymes were all located
adjacent to genes encoding homologs of Vi antigen biosynthesis
and export proteins (SI Appendix, Fig. S1A), supporting the hy-
pothesis that VexL is specifically involved in Vi antigen assembly
and/or processing rather than a catabolic pectinase.
VexL Is a Vi Antigen-Specific Lyase. We previously used VexL to
reduce the molecular weight of Vi antigen to isolate the terminal
glycolipid residue (16). The apparent molecular weight of Vi
antigen decreased in PAGE when incubated with VexL, and
purified glycolipids possessed a nonreducing terminal anhydro
residue (16) characteristic of lyase enzyme digestion (23, 24).
To investigate this activity in more detail, VexL was incubated
with purified Vi antigen, and reaction products were analyzed
by HPLC coupled to mass spectrometry (MS). Mass spectra
revealed species that differed by 217.059 m/z, which correspond
to oligosaccharides of GalNAcA, two to seven residues in length
(Fig. 3 and SI Appendix, Table S1). No monosaccharides were
detected, indicative of an endo-acting enzyme. MS also revealed
species that differed by −42.011 and −18.011 m/z, which rep-
resent nonstoichiometric O-acetylation of the polysaccharide,
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Fig. 1. Model for ABC transporter-dependent CPS assembly in Gram-
negative bacteria. The figure illustrates systems from an E. coli group
2 prototype and S. Typhi Vi antigen at different conceptual states in the CPS
envelope translocation process. CPS glycans are assembled from NDP-
activated glycose residues by cytosolic glycosyltransferase enzymes at the
cytoplasm-membrane interface (SI Appendix, Fig. S1B), before recognition
and export by the ABC transporter. The nascent glycans possess different
terminal glycolipids. Binding and hydrolysis of ATP by the cytoplasmic NBD
protein dimer drives conformational changes in the TMD that power se-
cretion of CPS across the inner membrane. The transporter is proposed to
engage the outer membrane OPX channel via interaction with a PCP
adaptor.
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and water loss, respectively. In all of the products, VexL creates a
nonreducing 4-deoxy-2-N-acetyl-α-D-galact-4-enuronosyl residue. This
modification appears in MS as an “anhydro” residue at the
nonreducing terminus (Fig. 3 and SI Appendix, Table S1). No
hydrated species (i.e., hydrolase products) were detected. Cross-
ring fragmentation products in MS2 were consistent with this
terminal modification (SI Appendix, Fig. S2). Formation of 4-
deoxy-α-D-galact-4-enuronosyl residues, which absorb at 232 nm
(SI Appendix, Fig. S3A), confirmed a lyase mechanism rather
than hydrolase and offered the opportunity to follow the reaction
by spectrophotometry (25). VexL degraded Vi antigen, generating
3.2 μmol·min−1·mg−1 nonreducing termini at its pH optimum of
5.5 (SI Appendix, Fig. S3B). Product formation was dependent on
O-acetylation of the glycan; no activity was detected for de-O-
acetylated Vi antigen or pectate (SI Appendix, Fig. S3A). VexL
activity was unaffected by EDTA, indicating no divalent cation(s)
was required for catalysis (SI Appendix, Fig. S3A).
Structure of VexL. To further characterize VexL, its 3D structure
was determined by X-ray crystallography. The gene construct
encoded the entire A. denitrificans VexL preprotein, including
the predicted N-terminal signal sequence and a C-terminal af-
finity tag. VexL-His6 was expressed in E. coli and purified from
the periplasm to ensure proper folding of the mature protein,
that might be affected by the oxidizing periplasmic environment
and signal peptidase processing. Initial optimized VexL crystals
diffracted to ≥2.8 Å (space group P 31). To improve resolution,
we incubated VexL-His6 with purified Vi antigen and screened
for new crystallization conditions. The addition of the glycan
did not affect the melting temperature of VexL; the Tm was
59.5 °C with 5 mg/mL Vi antigen. The resulting tetragonal
crystals diffracted to 1.22 Å (space group P 42 21 2). These data
were phased by molecular replacement, and discussion focuses
on this structure (Table 1). The asymmetric unit contains one
copy of VexL, a malonate ion (buffer), and a trisaccharide of
Vi antigen ([→4)-D-GalNAcA3Ac-α-(1→]3). In contrast, the
apo-structure was largely incomplete and differed from the
glycan-bound structure by 0.45 Å rmsd. Amino acid residues of
VexL are hereafter numbered based on the full-length pre-
protein sequence. VexL currently represents the most com-
plete and highest resolution structure for any active pectate
lyase in the PDB.
The VexL structure contains density for residues Cys28-Pro392,
Arg395-Gly402, and two His residues from the affinity tag. There
are three disulfide linkages: Cys28-Cys35, Cys279-Cys296, and
Cys364-Cys400. The majority of VexL is composed of a right-
handed parallel β-helix with three “faces” composed of parallel
β-sheets (Fig. 4 A and B). Each β-strand is connected to the
adjacent one by a short two- to four-residue loop. This forms a
compact “core,” which is packed with ordered arrays of aliphatic
and hydrophobic amino acids, contributed by each “rung” in the
β-helix (labeled 1 to 10) (Fig. 4B). The regular pattern is interrupted by
insertions that comprise a loop with an α-helix (rung 6; Leu199-Arg218),
a long loop with an α-helix (rung 9; Asn273-Arg305) that is sta-
bilized by a disulfide linkage (Cys279-Cys296) and salt bridge
(Asp252-Arg277), and a loop with an α-helix (rung 9; Asn314-Asp330) (SI
Appendix, Fig. S4A). These insertions result in two faces of the
β-helix being buried and the third face forming the base of an
extensive groove. This groove is populated by conserved (Fig. 4C) and
positively charged amino acids (Fig. 4D). The N terminus (Cys28-Pro85)
comprises two α-helices, a β-strand, and a long loop. The long
loop and long α-helix pack against one face of the β-helix. The
shorter α-helix and β-strand pack against the top end of the β-helix.
The C terminus (Gly343-Gly402) forms loops and a short α-helix that
cap the bottom end of the β-helix and then pack against the same
β-sheet as the N terminus and its neighbor (Fig. 5).
The cocomplex reveals clear electron density for three sugar
residues of Vi antigen, positioned within the large groove high-
lighted above (Fig. 4E). There is additional density that suggests
a longer polymer, but we were unable to unambiguously model
beyond the trisaccharide. The long axis of the trisaccharide mol-
ecule and the VexL β-helix align; the reducing sugar sits at the C-
terminal end of the β-helix, essentially level with the “base” of the
structure. The carboxylate group of the nonreducing sugar makes
a bidentate salt contact with the side chain of Arg235 while the
oxygen of the N-acetyl group is hydrogen bonded to Lys195 (SI
Appendix, Fig. S5G). The O4 of this sugar makes a hydrogen bond
with Arg232, and the pyranose ring oxygen (O5) hydrogen bonds to
Arg232 and water. There was no additional difference density for
an O-acetyl group of this sugar. The importance of these amino
acids was probed by site-directed mutagenesis. Purified peri-
plasmic VexL K195A, R232K, R232A, and R235A (SI Appendix,
Fig. S3C) were inactive in in vitro assays monitoring depolymer-
ization or formation of unsaturated termini (SI Appendix, Fig. S3
E and F), despite remaining folded (SI Appendix, Fig. S3D). VexL
R235K had 5% of WT activity. Gln237 hydrogen bonds to Arg235
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Fig. 2. Phylogeny of VexL pectate lyases. The figure depicts a phylogram of
VexL homologs, identified by position-specific iterative BLAST (19) of VexL
from Achromobacter denitrificans. The maximum-likelihood phylogram was
generated from 100 bootstrapped datasets using PhyML3.0 (64) and visu-
alized using iTOL (65). GenBank (84) accession numbers for VexL homologs
are listed in SI Appendix, Materials and Methods. Bootstraps are labeled as
purple circles.
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while Arg172 and Asp171 hydrogen bond to Arg232 through water.
VexL R172K had 44% of WT activity. Mutation of these “sup-
porting” residues to alanine reduced lyase activity by ∼50% (SI
Appendix, Fig. S3F), except for Arg172, which was inactive (SI
Appendix, Fig. S3 E and F).
The carboxylate of the central sugar is hydrogen bonded to
both Gln231 and Tyr295, and the oxygen atom of the N-acetyl
group is hydrogen bonded to water (SI Appendix, Fig. S5G). The
terminal oxygen atom of the O-acetyl group in this sugar is
bridged to the protein by hydrogen bonds to a water molecule.
The reducing sugar makes two hydrogen bonds to the protein,
Arg305 with oxygen atom of the N-acetyl group and Tyr298 with the
terminal oxygen atom of the O-acetyl group. In addition to the
hydrogen bonds, all three sugars make extensive van der Waals
contacts with the protein. Of particular note is the methyl group of
the O-acetyl of the middle sugar, which sits in a hydrophobic
pocket bounded by Tyr254 and Leu308. Altering this pocket re-
duced depolymerase activity; VexL Y254F has 47% of WT activity
(SI Appendix, Fig. S3F).
Vi Antigen Envelope Translocation Includes a Periplasm-Accessible
Intermediate. A predicted signal sequence suggested that VexL
is an exported protein. Proteins reactive with VexL-specific an-
tibodies were found associated with cells in three Achromobacter
species (SI Appendix, Fig. S1C). However, no protein or lyase
activity was detected in the spent media from cultures of these
bacteria, indicating that VexL resides in the cytoplasm or peri-
plasm of its natural host, rather than being a substrate for a
protein secretion system (SI Appendix, Fig. S4C). Material re-
active with Vi antigen-specific antibodies was identified in lysates
of these Achromobacter species, suggesting that these Achromo-
bacter do produce a glycan resembling Vi antigen (SI Appendix,
Fig. S1C). To the best of our knowledge, CPS-specific depoly-
merases are not found in other ABC transporter-dependent as-
sembly systems, and we reasoned VexL might offer insight into
this process. However, investigating the role of VexL in Vi an-
tigen production in Burkholderiales is complicated by the absence
of information concerning both the diversity of polysaccharides it
produces and the underlying biology (i.e., glycan function and
growth conditions that affect Vi antigen synthesis). An additional
barrier is the resistance of Achromobacter isolates to antibiotics
used as markers in molecular genetic tools (26). We therefore
chose to examine the impact of VexL in the characterized
S. Typhi system. We argue that this heterologous system is a valid
model to examine glycan accessibility in the export pathway be-
cause these organisms possess essentially identical Vi antigen
biosynthesis and export proteins (SI Appendix, Fig. S1A). However,
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Fig. 3. Oligosaccharide profile of VexL reaction products. Shown is a charge-deconvoluted QToF mass spectrum of Vi antigen oligosaccharides generated by
VexL depolymerization. Ions correspond to polymers of O-acetylated HexNAcA residues, from two to seven residues in length (yellow box symbols), with a
nonreducing terminal 4-deoxy-α-D-galact-4-enuronosyl residue (gray box). Species with nonstoichiometric O-acetylation [Δ42.010 atomic mass units (amu)]
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Table 1. Crystallographic data collection and refinement
statistics
Data collection
Space group P 42 21 2
Cell dimensions
a, b, c, Å 94.7, 94.67, 78.8
α, β, ɣ, ° 90, 90, 90
Resolution, Å 60.6–1.22
(High resolution) (1.24–1.22)
Rmerge 0.07 (1.42)
I/σI 17.0 (2.1)
Completeness, % 100 (100)
Average redundancy 12.8 (12.7)
Vm, Å3/Da 2.05
Solvent, % 40.0
Refinement
No. of unique reflections 106,029
Rwork/Rfree, % 14.0/16.6
No. of atoms (non-H)
Protein 2,978
Water 243
Vi antigen 52
Malonate 7
B-factors, Å
Protein 19.3
Water 29.7
Vi antigen 31.1
Malonate 35.4
rms deviations
Bond lengths, Å 0.012
Bond angles, ° 1.51
Ramachandran
Favored, % 95.4
Disallowed, % 0
Molprobity score/centile 1.12/97
PDB 6FI2
Liston et al. PNAS | vol. 115 | no. 21 | E4873
M
IC
RO
BI
O
LO
G
Y
PN
A
S
PL
U
S
S. Typhi does not encode VexL, and A. denitrificans does not
encode TviA, a transcriptional activator of the Vi antigen locus
unique to S. Typhi (27, 28).
S. Typhi was transformed with inducible plasmid vectors encoding
A. denitrificans VexL-His6, VexL R232A-His6, or VexL
24-402-His6
(which lacks the signal sequence). To confirm localization of
these constructs in S. Typhi, released periplasmic contents were
examined by immunoblotting employing VexL-specific antibodies.
As expected, VexL and VexL R232A appeared in the periplasmic
fraction whereas VexL24-402 was confined to the cytoplasm and
remained within spheroplasts (SI Appendix, Fig. S4A). Expression
of VexL-His6 reduced the average molecular weight of Vi antigen
(Fig. 5A) while the catalytically inactive VexL R232A-His6 (Fig.
5A) did not, confirming that the change in molecular weight is a
specific catalytic effect rather than a structural consequence of
overexpression of periplasmic VexL-His6. In contrast, cytoplas-
mic VexL24-402-His6 had no effect on Vi antigen profiles (Fig.
5A), indicating that any degradation of product occurred postex-
port from the cytosol. The Vi antigen produced by cells expressing
VexL variants was located on the cell surface in S. Typhi judged
by susceptibility to the Vi antigen-specific bacteriophage ViII
(Fig. 5B). Growth media from these cultures was examined, but
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Fig. 4. Crystal Structure of A. denitrificans VexL-His6 with bound Vi Antigen. (A) The graphic representation of VexL was generated from a 1.22-Å diffraction
dataset collected from a single crystal of VexL-His6 bound to a trisaccharide of purified Vi antigen. The diagram is colored in rainbow from N terminus (blue)
to C terminus (red). (B) Topology of A. denitrificans VexL. Secondary structure elements are colored turquoise (β-sheets) or orange (α-helices). Disulfide
linkages are colored red. Thick (3 pt) lines represent β-sheets and loops above the plane of the page. (C) Amino acid conservation of VexL with the bacterial
and plant pectate lyases described in Fig. 2. Conservation scores were mapped to the VexL structure using ConSurf and displayed on the solvent-accessible
surface (68). (D) Electrostatic surface potential for VexL was calculated at pH 6.5 using the Adaptive Poisson-Boltzmann Solver (66) and is displayed from
−3 kT/e (red) to +3 kT/e (blue). (E) VexL structure with bound Vi antigen depicted as yellow sticks. (Inset) The 2FO − FC electron density map contoured at 1σ
for the bound trisaccharide, as gray mesh. The reducing and nonreducing sugar residues are labeled.
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no VexL protein was detected in the spent media by immunoblot-
ting (SI Appendix, Fig. S4B). Moreover, no degradation of purified
Vi antigen was evident after incubation with these media, unless the
cells were mechanically disrupted (SI Appendix, Fig. S4C). These
data ruled out any unanticipated effect occurring at the cell surface
from small amounts of VexL released during growth. These ex-
periments are entirely consistent with a model in which Vi an-
tigen is protected within the cytoplasm during biosynthesis but
exposed in the periplasm during translocation.
The inability of cytosolic VexL24-402-His6 to affect the Vi an-
tigen profiles was surprising. To examine this phenotype in more
detail, VexL24-402-His6 was expressed in S. Typhi ΔvexC, which
lacks the ABC transporter NBD. This mutation interrupts Vi
antigen export and leads to accumulation of glycan in the cytosol
(14, 16). As expected, this strain was resistant to infection by
bacteriophage ViII (Fig. 5B). In contrast to WT S. Typhi, vexC
mutant Vi antigen was susceptible to degradation by VexL24-402
(Fig. 5A), which confirmed that VexL24-402 is active in vivo and can
access its substrate if the normal assembly pathway is perturbed.
Discussion
VexL shares a conserved β-helical structure with diverse bacte-
rial and plant catabolic polysaccharide lyases found in families
PL1, PL3, and PL9 of the Carbohydrate-Active Enzyme (CAZy)
database (29, 30). The representative structures of these protein
families differ predominately in the position of loops inserted at
turns that frame the glycan-binding site(s) but have little varia-
tion within the β-helix itself, suggesting that these elaborations
are important for substrate recognition. Close structural homo-
logs of VexL (SI Appendix, Fig. S5 and Table S4) belong to
family PL1, which contains metal-dependent, endo-acting, pectin
and pectate lyases with alkaline pH optima (24, 29). Despite the
existence of dramatically different polysaccharide lyase folds
[e.g., (α/α)3 barrel, PL10], their catalytic centers for trans-β-elimi-
nation are conserved (31). The reaction employs an arginine
residue positioned to extract a proton from C4 of the hexuronic
acid residue in the +1 subsite (24). In VexL, we suggest that
Arg232 fills this role. This is supported by inactivating mutations
in VexL R232K (conservative) and R232A and the position of
this residue relative to C4 of GalA4 in the +1 subsite of the
Dickeya dadanti PelC–GalA4 complex (SI Appendix, Fig. S5H)
(21). D. dadanti PelC includes an additional conserved arginine
(Arg245) (SI Appendix, Fig. S5H) that is involved in a ligand-
positioning bidentate salt contact with the carboxylate of the
GalA residue in the −1 subsite. In VexL, Arg235 fills this role (SI
Appendix, Fig. S5G), and, as such, we propose that the tri-
saccharide of Vi antigen in the VexL structure represents glycan-
binding subsites −3, −2, and −1. The hydrogen-bonding network
involving Vi antigen N- and O-acetyl decorations (SI Appendix,
Fig. S5G) is a critical component of substrate recognition; all
point mutants of interacting residues had reduced lyase activ-
ity (SI Appendix, Fig. S3F). The specific requirement for the
O-acetyl group is achieved not through a single interaction but
rather through a network involving bridging water molecules. We
propose that using a network, as opposed to a single interaction,
underpins the tolerance of VexL for nonstoichiometric O-acet-
ylation of its substrate. Notably, the VexL-binding groove lacks
multiple DXD motifs, which coordinate divalent cations essen-
tial for glycan binding and activity in conventional pectate lyases,
such as D. dadanti PelC (29) (SI Appendix, Fig. S5 G and H). The
lack of sensitivity to EDTA supports the conclusion that VexL
does not require a divalent cation(s) for catalysis. VexL has a
signal peptide, a pH optimum more acidic than other relative
enzymes (pH 5.5 vs. ∼8.0 to 9.5), and presence of multiple
disulfide linkages that we suggest stabilize the N and C termini of
the protein. Because of these unique properties, we propose that
VexL has evolved unique structural changes and catalytic fea-
tures that facilitate function in the more acidic (32) and oxidizing
environment of the periplasm; VexL is a distinctive and unusual
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encoded protein expression with indicated final concentration of L-arabinose for 30 min. (B) Expression of VexL or VexL24-402 does not eliminate susceptibility
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addition to polysaccharide lyase family 1, that defines a robust
subfamily with unusual polysaccharide lyase activity.
This work confirms that VexL is a periplasmic CPS-degrading
enzyme. This feature is absent from all other known CPS as-
sembly systems that use ABC transporters. However, periplasmic
glycan-modifying proteins participate in production of some se-
creted exopolysaccharides (EPSs) that feature different biosynthesis
and export machinery. These enzymes include polysaccharide
lyases, hydrolases, epimerases, and acetylesterases that modify
nascent EPS glycans nonstoichiometrically as they transit the
periplasm. In some examples, these enzymes participate in the
envelope translocation protein complex and are therefore
sometimes required for glycan assembly and/or export. The
Pseudomonas aeruginosa PEL polysaccharide provides an ex-
ample. Unlike CPS, PEL does not possess a terminal lipid (33);
its secretion requires a multidrug and toxic compound extrusion
(MATE) transporter and a periplasmic scaffold that guides PEL
to an outer membrane channel. PelA is a periplasmic PEL
acetylesterase and hydrolase that binds the scaffold (34) and is
required for PEL production (35). Similarly, E. coli poly-N-
acetylglucosamine EPS employs a periplasmic acetylesterase
(PgaB) that is required for export but not synthesis (36). In
contrast, production of the (Wzx-dependent) P. aeruginosa PSL
EPS does not require the cognate PslG periplasmic hydrolase
although PslG overexpression decreases PSL production and
biofilm formation (37). The P. aeruginosa EPS alginate assembly
machinery encodes a periplasmic lyase (AlgL). AlgL is proposed
to degrade periplasmic glycan that has escaped the export ma-
chinery, and deletion of algL does result in the accumulation of
periplasmic glycan that results in cell lysis. However, AlgL also
interacts with the secretion complex so interpretation of the
phenotype is complicated (38, 39).
It is hard to argue that VexL would be required for Vi antigen
export in the Burkholderiales given the overall similarity of the Vi
antigen export machinery to examples from other bacteria, and
homology to S. Typhi Vi antigen export proteins, which do not
include VexL. The structure of VexL does not include any ob-
vious domain that would point to an interaction with the CPS-
translocation complex, and expressing a catalytically inactive
VexL had no effect on the normal export process in S. Typhi.
Furthermore, cognate periplasmic glycanases are not found in
ABC transporter-dependent CPS assembly systems in other
bacteria, which one would anticipate if this assembly strategy was
intrinsically susceptible to aberrant and physiologically harmful
accumulation of periplasmic glycan.
EPS/CPS produced by systems employing periplasmic glycan-
depolymerizing or modifying enzymes do not share obvious
structural features that might dictate a functional requirement
for these enzymes. The EPS examples are frequently associated
with biofilm formation, and this seems the most likely role for
the Vi antigen-like glycan produced by the Burkholderiales. Al-
though some Achromobacter isolates are opportunistic human
pathogens (26, 40, 41), vexL-containing Vi antigen assembly loci
are found predominantly in soil bacteria, where the role for Vi
antigen has yet to be examined. Defining a biologically relevant
role for any surface glycan is challenging without detailed in-
formation about the organisms’ lifestyle and prevailing envi-
ronmental conditions that might impact glycan production. Vi
antigen is a major constituent of biofilm matrices in S. Typhi
biofilms grown on gall stones ex vivo (42) but is apparently dis-
pensable for biofilm formation in this setting (43). In contrast, Vi
antigen production in S. Typhi is unequivocally linked to de-
creasing complement deposition and immune clearance (44). Vi
production is up-regulated when S. Typhi enters intestinal epithelial
cells, reduces complement and Toll-like receptor-dependent
detection, and decreases recruitment of immune effectors to
the site of infection (45–48). Vi antigen purified from S. Typhi is
viscous; this property is related to glycan chain length and di-
minished by VexL treatment (16). It is therefore tempting to
speculate that the gain or loss of an enzyme that alters the chain
length, release, and/or quantity of CPS produced may be a crit-
ical factor in the function(s) of the Vi antigen in organisms with
different physiologies and niches. How glycan depolymerizing
and modifying activities contribute to biofilm formation is an
open question. The relationships between quantity, chain length,
physical properties, and function(s) of glycans in natural biofilms
are currently poorly understood. However, the importance of
EPS is reinforced by the successful application of EPS-specific
glycanases as therapeutics to disrupt biofilms produced by path-
ogenic bacteria (4) and fungi (49, 50).
Regardless of its function in the natural host, VexL provided a
molecular probe to generate important insight into the secretion
machinery for Vi antigen in S. Typhi. Given the overall simi-
larities in their export machineries, the findings are potentially
relevant for other ABC transporter-dependent CPS assembly
systems (2, 7). Understanding the details of these processes is
vital in considering CPS as a therapeutic target in antivirulence
strategies. We establish that the Vi antigen is protected from
VexL degradation during its synthesis in the cytoplasm. This
could be accomplished by a complex of biosynthetic enzymes
creating a protected environment for the glycan or by tight
coupling of polymerization and export, such that the glycan is
exported as it is polymerized. Such coupling occurs in the syn-
thesis of some O antigenic polysaccharides which couple a
multiprotein synthesis complex to an ABC transporter (51, 52).
Coupling synthesis and export of O antigen regulates product
chain length, and a similar effect is evident in the increased
molecular weight of Vi antigen in the vexCmutant (Fig. 5A). The
observation that the Vi antigen becomes susceptible to cyto-
plasmic degradation in the absence of export suggests that there
is normally a protected cytosolic “compartment” but does not on
its own distinguish between an enveloping protein complex or
coupling-mediated effect. However, the susceptibility of cytosolic
Vi antigen accumulating in export-deficient mutants leads us to
favor the latter explanation.
Previous studies used recombinant bacteriophage-derived
endoglycanase enzymes to examine the cytoplasmic accessibility
of CPS during its synthesis in E. coli K1 (53) and K5 (54). In both
cases, CPS degradation was assessed by susceptibility of the bac-
teria to the corresponding CPS-specific bacteriophage (an in-
dicator of some exported CPS). In K5, CPS production was
directly quantified (54). Surprisingly, these studies yielded differ-
ent conclusions. The authors concluded that K1 (53) was synthe-
sized in a protected cellular compartment, but K5 was not (54).
We recapitulated the experiments with E. coli K1 and found that
it retained susceptibility to the CPS-specific bacteriophage (as
reported in ref. 53), but, when the CPS was examined by immu-
noblotting, most was degraded by the cytoplasmic glycanase (SI
Appendix, Fig. S6). This result is more consistent with those
obtained with E. coli K5, and the different conclusions may reflect
the different approaches and bacteriophages used to assess phe-
notypes. Neither system offers the cytoplasmic protection seen for
Vi antigen, and this may reflect the differences in biosynthetic
machinery and glycolipid acceptors used by E. coli and S. Typhi.
The organization of the reported biosynthesis complex (53, 55, 56)
would therefore appear to differ from that for Vi antigen.
Our results demonstrate that the Vi antigen can be degraded
by VexL during the translocation phase in the periplasm. This
finding is inconsistent with the current assembly model (Fig. 1)
and raises questions that will only be answered with solved
structures. The model was influenced by the ABC transporter-
based tripartite drug efflux pumps (7), such as the MacA–MacB–
TolC complex (11). A prototype OPX protein from the Wzx-
dependent export of E. coli “Group 1” CPS forms a multimeric
channel across the outer membrane (57) and interacts with its
inner membrane (periplasm-exposed) PCP partner (58). In the
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group 2 E. coli K5 system, a multiprotein complex has been
detected that contains the ABC transporter (KpsMT), the PCP
protein (KpsE), and the OPX protein (KpsD) (55). Further-
more, genetic data support cognate interaction between PCP-
OPX protein pairs in other group 2 systems (59). Although
there is currently no structural data for KpsD, the PCP protein
KpsE forms a membrane-bound multimeric structure in cryo-
EM whose periplasmic domain resembles the adaptor complex
of tripartite drug efflux pumps (59). While the size and com-
plexity of the CPS substrate and structures of efflux pumps have
made the concept of a protected translocation pathway attractive
as a working model, the accessibility of Vi antigen to degradation
in the periplasm indicates that this must be reassessed. In group
1 systems, CPS polymerization occurs in the periplasm external
to the PCP–OPX complex, and the glycan is proposed to access
the lumen of the complex laterally (58). Site-directed cross-
linking experiments established that CPS glycans transit the
outer membrane within the OPX pore (60). The results presented
here indicate that periplasmic access to the translocation pathway
is also required in group 2 systems. Periplasmic exposure of the
glycan may offer interesting avenues for CPS structural diversi-
fication. For example, LPS O antigens exported by ABC trans-
porters are exposed during assembly/translocation and can be
substrates for postpolymerization periplasmic glycosylation sys-
tems, creating altered structures and antigenic epitopes (61).
Experimental Procedures
Molecular Biology. Oligonucleotide primers were obtained from Sigma-
Aldrich and are described in SI Appendix, Table S3. DNA fragments were
generated by PCR employing primers that introduced restriction sites for use
in cloning, digested using appropriate restriction enzymes (NEB; Invitrogen),
and ligated to digested vector DNA using T4 DNA ligase (NEB). Site-directed
mutants were generated using KOD HotStart DNA polymerase (Novagen)
with primers containing point mutations (SI Appendix, Table S3), according
to the QuikChange method (Stratagene). All DNA constructs were confirmed
by sequencing at the Genomics Facility, Advanced Analysis Centre, University
of Guelph, and are described in SI Appendix, Table S4.
Bioinformatic Analyses. Homologs of VexL were identified using a position-
specific iterative BLAST search of the nonredundant protein sequence da-
tabase. Initial hits from Achromobacter were selected to generate a VexL-
specific blocks substitution matrix (BLOSUM), which was used in the second
iteration (19). The top 500 hits were selected; hypothetical, predicted,
“low-quality,” and “multispecies” hits were removed. A multiple sequence
alignment was generated using MUSCLE (62). Dickeya dadanti PelA, PelC,
and Bacillus sp. N16-5 PelA were included in multiple sequence alignments
due to structural similarity to VexL but did not appear as hits in position-
specific iterative (PSI)-BLAST. Conserved blocks for phylogenetic analysis
were defined using Gblocks (63). A maximum-likelihood phylogram was
generated from 100 bootstrapped datasets using PhyML3.0 (64) and visu-
alized by iTOL (65). Surface electrostatics were calculated using the Adaptive
Poisson-Boltzmann Solver (APBS) (66). The PQR file, for use in APBS, was
generated using PDB2PQR (67); pKa were calculated by PROPKA at pH 6.5
(pH of crystallization). Conservation of amino acid residues was mapped
to the VexL structure using ConSurf (68), employing the multiple se-
quence alignment and phylogram described above. Structural homologs
of VexL were identified using PDBeFold (69). Figures were generated in
PyMol (Schrödinger).
Purification of VexL-His6 and Mutant Derivatives. For crystallography, Achro-
mobacter denitrificans VexL was purified from the periplasm of E. coli
C43 transformed with pWQ791, which encodes C-terminally hexahistidine-
tagged VexL. Purification employed release of periplasmic contents by os-
motic shock, followed by immobilized metal affinity and gel filtration
chromatography, which was adapted from ref. 16 (SI Appendix, Materials
and Methods).
Purification and VexL-Mediated Digestion of Vi Antigen. Vi antigen was puri-
fied from S. Typhi CWG1239 (ΔvexE ΔwaaG::kan) using hot aqueous phenol
extraction, hexadecyltrimethylammonium bromide precipitation, and enzy-
matic digestion of DNA/RNA/protein, and then by gel filtration chroma-
tography (16). This polysaccharide lacks the terminal glycolipid residue that
could have interfered with crystallization. Purified Vi antigen was incubated
with purified VexL-His6 and then analyzed by reversed-phase liquid chro-
matography (Agilent 1200, Extend-C18 column) coupled to tandem quad-
rupole time-of-flight (QToF) MS in negative ion mode (Agilent UHD 6530).
See SI Appendix, Materials and Methods for details.
Lyase Enzyme Assay. VexL lyase activity was determined by spectrophoto-
metric assay monitoring absorbance at 232 nm (SI Appendix, Materials and
Methods) (25).
Crystallization of VexL-His6, Crystallographic Data Collection, Refinement, and
Analysis. Before crystallization, VexL-His6 was diluted to 13.5 mg/mL (A280)
and incubated with purified Vi antigen at 5 mM (estimated based on the MW
of GalNAcA3Ac4, the most abundant product identified in MS; 1,036.27 g/mol)
(Fig. 3). This mixture was incubated at 37 °C for 1 h and then centrifuged at
16,000 × g, 4 °C for 10 min before crystallization. Sparse matrix screening of
the sample was performed using a combination of commercial and in-house
crystallization screens. All experiments were set up as sitting drops, at 20 °C,
using a Crystal Gryphon robot (Art Robbins) at drop ratios of 1:1 and
2:1 protein-precipitant in 300 and 450 nL of total drop sizes, respectively.
After 1 d, UV-bright crystals were evident in 1.63 M sodium malonate, 0.1 M
BisTris-HCl, pH 6.5, 0.08 M ammonium citrate, and 3.05% (vol/vol) 2-methyl-
2,4-pentanediol. Drops were scaled up to 1.0 and 1.5 μL, and the mother
liquor was refined to 1.58 M sodium malonate, 0.1 M BisTris-HCl, pH 6.5,
0.13 M ammonium citrate, and 2.5% (vol/vol) 2-methyl-2,4-pentanediol. To
augment Vi antigen binding, 1 d before data collection, crystals were
transferred to a drop of mother liquor supplemented with 10 mM Vi an-
tigen and allowed to rest there overnight.
Crystals were harvested from Vi antigen-supplemented mother liquor and
flash cooled directly in liquid nitrogen, without further addition of cryo-
protectant. Data were collected at −173 °C on beamline id23-1 at the
European Synchrotron Radiation Facility with automated data processing (70,
71). The structure was solved by molecular replacement using Balbes (72) via
the online CCP4 server (73). Automatic model building was performed with
Buccaneer (74), followed by manual rebuilding after interpretation in Coot
(75). At this stage, density was visible to place a trisaccharide of Vi antigen. A
library for Vi antigen was generated using PRODRG (76) and implemented
during model refinement in REFMAC5 (77) and PDBREDO (78). The structure
was validated using Molprobity (79) and deposited in the PDB (6FI2).
Subcellular Localization of VexL-His6 and Mutant Derivatives. Cultures of
S. Typhi H251.1 harboring plasmid-encoded VexL-His6, or mutant derivatives,
were grown in 250 mL of lysogeny broth using the conditions described in In
Vivo Lyase Accessibility Assay. Periplasmic contents were released by osmotic
shock (500 mM Sucrose, EDTA, and lysozyme) and further fractionated by
differential centrifugation. These samples were then used for western im-
munoblotting. Spent cell-free culture media were concentrated and ana-
lyzed for the presence of VexL by immunoblotting and by incubating with
purified Vi antigen. See SI Appendix, Materials and Methods.
In Vivo Lyase Accessibility Assay. Five milliliters of lysogeny broth cultures,
supplemented with 100 μg/mL ampicillin, 0.2% (wt/vol) glucose, and 100 μg/mL
2,3-dihydroxybenzoic acid, were inoculated with S. Typhi H251.1, which
harbored either pWQ791, pWQ935, or pWQ939, and grown for 16 h, at
37 °C. Then 1 OD600 unit equivalent of cells was collected and washed twice
with 1 mL of sterile PBS and used to inoculate (at 1:1,000) 5 mL of fresh
growth media without glucose. Cultures were grown at 37 °C until OD600
reached 0.5. Expression of the VexL derivatives was then induced with the
indicated final concentrations of L-arabinose, and growth was continued for
30 min. One OD600 unit equivalent of cells was collected by centrifugation at
10,000 × g for 1 min, immediately resuspended in Laemmli loading buffer
(80), and incubated at 100 °C for 10 min. Samples were then used for im-
munoblotting using Vi antigen-specific antibodies.
Bacteriophage-Sensitivity Assays. Half of an LB agar plate was inoculated with
3 × 108 pfu of bacteriophage Vi II (HER no. 39; Félix d’Hérelle Reference
center for Bacterial Viruses, Université Laval) or 2 × 109 pfu of bacteriophage
K1F (81). LB agar plates contained 100 μg/mL ampicillin and 0.02% (wt/vol)
L-arabinose or 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), to induce
plasmid-encoded gene expression. Plates were dried at room temperature.
Then, 8 μL of stationary-phase cultures were dropped onto the phage-free
side of the plate and then tipped to the phage-inoculated area. Plates were
incubated at 37 °C for 5 h and then imaged using an EPSON Perfection 2450
Photo scanner.
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Generation of VexL-Specific Polyclonal Antibodies. Purified VexL-His6 was
resuspended at 50% (vol/vol) in Freund’s incomplete adjuvant and used to
immunize a female New Zealand white rabbit by intramuscular injection at
four surgically prepared sites. The Animal Utilization Protocol was approved
by the University of Guelph Animal Care Committee, and all procedures
were performed by Animal Care Services at the Central Animal Facility at the
University of Guelph. Antibodies were purified from sera by VexL-affinity
chromatography, concentrated, and stored at −80 °C (SI Appendix,Materials
and Methods).
PAGE and Immunoblotting. Whole-cell lysates were prepared by collecting
1 OD600 unit equivalent of cells resuspended in 100 μL of loading buffer (80).
SDS/PAGE samples were incubated at 100 °C for 10 min, before electro-
phoresis [Tris-Glycine, 10% (wt/vol) acrylamide]. Protein gels were stained
with Coomassie Brilliant Blue R-250. For immunoblotting, protein samples
were transferred to nitrocellulose membranes (0.45 μm; Amersham Protran).
Primary antibodies were murine monoclonal anti-His5 (diluted 1:3,000;
Qiagen), murine monoclonal anti-RNA polymerase α (sc-101597; diluted
1:2,000; Santa Cruz Biotechnology), murine anti-MalE (diluted 1:20,000;
NEB), rabbit anti-OmpA (diluted 1:3,000; gift from Thomas Silhavy, De-
partment of Molecular Biology, Princeton University, Princeton) (82), or
purified polyclonal rabbit anti-VexL-His6 (diluted 1:3,000; this work). Secondary
antibodies were horseradish peroxidase (HRP)-conjugated goat anti-mouse
(diluted 1:3,000; Qiagen) or HRP-conjugated goat anti-rabbit (diluted 1:3,000;
Qiagen); detection employed HRP-substrate Luminata Classico (Millipore).
To analyze polysaccharides in whole-cell lysates, samples were prepared as
above and then incubated with 50 μg of proteinase K for 1 h at 55 °C. The
lysates were then separated by SDS/PAGE and transferred to PVDF or nylon
membranes (BioDyne B; Pall). Membranes were probed with murine mono-
clonal anti-Vi antigen antibody P2B1G2/A9 (diluted 1:350) (83), or anti-polysialic
acid-NCAM antibody (MAB5324 clone 2-2b, diluted 1:1,000; Millipore Sigma),
followed by alkaline phosphatase-conjugated goat anti-mouse secondary
antibody (diluted 1:3,000; Qiagen). Detection employed nitro-blue tetrazo-
lium and 5-bromo-4-chloro-3-indolyl phosphate (Roche).
For purified polysaccharide, 1 μL of 2 M sucrose was added to 5 μL of
sample (typically at 1 mg/mL Vi antigen) and loaded into 15% (wt/vol) ac-
rylamide, 89 mM Tris, pH 7.6, 89 mM boric acid, and 2 mM EDTA minigels, for
electrophoresis at 250 V for 70 min. Gels were stained for 16 h with 0.125%
(wt/vol) Alcian blue, 10% (vol/vol) acetic acid, and 25% (vol/vol) ethanol,
destained with 10% (vol/vol) acetic acid, 10% (vol/vol) ethanol for 1 h, and
then developed using the Pierce Silver Stain kit.
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